Cardiac allograft function with corticosteroid-free maintenance immunosuppression.

Area of Science:

• Immunology
• Cardiology
• Transplantation Medicine

Background:

• Potent immunosuppressive protocols facilitate corticosteroid withdrawal in transplant recipients.
• Corticosteroid-free maintenance offers benefits like reduced infections, obesity, and improved lipid profiles.
• No increase in allograft coronary artery disease incidence is observed with corticosteroid-free maintenance.

Purpose of the Study:

• To evaluate the long-term effects of corticosteroid-free immunosuppression on allograft function.
• To compare hemodynamic and noninvasive evaluations in patients with and without corticosteroid maintenance.

Main Methods:

• A 2-year follow-up study comparing 57 patients on corticosteroid-free maintenance with 40 patients requiring corticosteroids.
• Assessment included hemodynamic studies and noninvasive evaluations of allograft function.
• Patient demographics, pretransplantation diagnoses, and survival rates were analyzed.

Main Results:

• Allograft function indexes, including ejection fraction and cardiac index, were similar between groups.
• Hemodynamic parameters such as pulmonary artery pressure and left ventricular end-diastolic dimension showed no significant differences.
• Patient survival was identical at 98% in both the corticosteroid-free and corticosteroid maintenance groups.

Conclusions:

• Corticosteroids can be safely withdrawn in transplant recipients under potent prophylactic immunosuppression.
• Corticosteroid-free maintenance provides early clinical benefits.
• Long-term allograft function and patient survival are not compromised by discontinuing corticosteroids.